Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis

Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure

(2011) Charlotte Andersson et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

(2011) Tina Ken Schramm et al.   EUROPEAN HEART JOURNAL

The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A retrospective analysis

(2010) K. M. Pantalone et al.   DIABETES CARE

Impact of Type of Preadmission Sulfonylureas on Mortality and Cardiovascular Outcomes in Diabetic Patients with Acute Myocardial Infarction

(2010) Marianne Zeller et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

(2009) Kevin M. Pantalone et al.   ACTA DIABETOLOGICA

Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study

(2009) Mykola Khalangot et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study

(2009) Henriette T. Horsdal et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy

(2008) D. M. Nathan et al.   DIABETOLOGIA